Skip to main content
. 2021 Feb 12;2021(2):CD013587. doi: 10.1002/14651858.CD013587.pub2

Comparison 4. HCQ versus febuxostat for treatment.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
4.1 Death due to any cause 1 54 Risk Ratio (M‐H, Random, 95% CI) Not estimable
4.2 Admission to hospital 1 54 Risk Ratio (M‐H, Random, 95% CI) 1.16 [0.26, 5.24]